The company operates tele-care and telemedicine centers, physiotherapy centers, radiology centers, medical rehabilitation centers, and alternative medicine clinics. Founded in 2015, Future Care has positioned itself as a diversified healthcare provider targeting both institutional and individual patient segments across Saudi Arabia's growing healthcare market.
Cyborg Score Rationale
Revenue grew 49.39% to 50.98 million SAR in 2023 with earnings up 166.50%, showing strong operational momentum. However, market cap declined 70.84% in one year as of mid-2025, indicating investor concerns despite operational growth. The company operates in a strategic healthcare sector but faces capital market challenges.
Top Insights
Revenue grew 49% YoY to ~51M SAR in 2023 with 166% earnings expansion, demonstrating operational scalability
Market cap severely contracted 70% year-over-year despite operational growth, signaling shareholder value destruction or sentiment reset
Diversified service portfolio spanning 9+ healthcare verticals (hospitals, clinics, telemedicine, labs, rehabilitation) reduces dependency on single service line
Positioned in Saudi Arabia's high-growth healthcare sector benefiting from Vision 2030 health infrastructure expansion
Named Competitors
Integrated Medical Services — Multi-specialty hospital and clinic chain across Middle East
Hospital Networks — Specialized hospital system with surgical and specialty focus
Pharmaceutical and Medical Services — Pharmacy and medical supply distribution
Recent Developments
(May 2025) Market cap declined to 1.63B SAR, down 70.84% from prior year
(2023) Revenue surged 49.39% YoY to 50.98M SAR with net earnings jumping 166.50%
(Mar 2026) Stock trading at 3.25 SAR showing continued weakness with negative momentum
Open the full interactive Future Care Trading Company report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.